Results for: oncology+products

Exclusive: Amgen's new leukemia drug to carry $178,000 price tag

Google researching use of color in business

Google Finds There's Power in Color

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test

Bartolo Colon suspended 50 games for positive test

Pfizer earnings dip on patent expirations, taxes

CEO: Risks key for Merck to succeed, help patients

US moves to regulate e-cigarettes

Pfizer sales way off mark as company pursues AstraZeneca

Pfizer's weak drug pipeline fuels hunger for AstraZeneca

Exclusive - 'Back to normal' for AstraZeneca CEO, despite Pfizer rumours

Pfizer sales way off mark as company pursues AstraZeneca

AstraZeneca rejects sweetened Pfizer takeover bid

Deal fever hits global pharma sector

Roche's $8 billion InterMune buy not a signal for more big deals

Cold caps tested to prevent hair loss during chemo

Ziopharm takes bigger loss as research costs grow

Stocks gain, pushing the S&P 500 to 5-year high

Pfizer's need for deal looms larger with earnings report

GSK to axe U.S. jobs as part of $1.6 billion cost cuts: sources

AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer

Merck explores $15 billion-plus drug portfolio sale - sources

Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

Weak Merck sales overshadow third quarter cost cuts

Pfizer Cancer Pact With Merck May Show Waning Astra Pursuit

EU antitrust regulators to decide on Novartis, GSK deals by January 14

Exclusive - Sanofi explores $7 billion-plus sale of drug portfolio: sources

'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

Promising cancer drug data helps AstraZeneca in Pfizer fight

Concerns about cancer centers under health law

Correction: Thermo Fisher-Life Technologies story

Roper will buy Managed Healthcare for $1 billion

Dendreon shares rise 4Q Provenge sales increase

Ziopharm's most advanced drug fails in study

Shake-up in pharma world as Novartis, GSK announce mega-deals

China's love and dating scene laid out on stage

EU antitrust regulators to decide on Novartis, GSK deals by Jan 14